






















![]()
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Vincent Anzalone - Head of Investor Relations & VP
Dr. Christopher Anzalone - Chairman, CEO & President
Andy Davis - SVP of Cardiovascular & Head of Metabolic Franchise
James Hamilton - Chief Medical Officer and Head of R&D
Daniel Apel - Chief Financial Officer
Conference Call Participants
Edward Tenthoff - Piper Sandler & Co., Research Division
Jason Gerberry - BofA Securities, Research Division
Ron Feiner - JPMorgan Chase & Co, Research Division
Avraham Novick - Morgan Stanley, Research Division
Maurice Raycroft - Jefferies LLC, Research Division
Joseph Thome - TD Cowen, Research Division
Patrick Trucchio - H.C. Wainwright & Co, LLC, Research Division
Amine Chaherli
Shelby Hill - RBC Capital Markets, Research Division
Jennifer Jia
Kaey Nakae - Chardan Capital Markets, LLC, Research Division
Presentation
Operator
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. [Operator Instructions]
I will now hand the conference call over to Vince Anzalone, Senior Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.
Vincent Anzalone
Head of Investor Relations & VP
Good afternoon, and thank you for joining us today to discuss Arrowhead's results for its fiscal 2026 second quarter ended March 31, 2026. With us today from management are President and CEO, Dr. Chris Anzalone, who will provide an overview; Andy Davis, Senior Vice President and Head of the Global Cardio Metabolic franchise, who will provide an update on commercialization activities; Dr. James Hamilton, Chief Medical Officer and Head of R&D, who will discuss our development programs; and Dan Apel, Chief Financial Officer, who will give an overview of the financials. Following management's prepared remarks, we will open the call to questions.
Before we begin, I would like to remind you that comments made during today's call contain certain forward-looking statements within the meaning of Section 27A of
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。